Literature DB >> 28127936

Are there new advances in the pharmacotherapy of autism spectrum disorders?

Eric Hollander1, Genoveva Uzunova1.   

Abstract

Entities:  

Year:  2017        PMID： 28127936      PMCID： PMC5269487          DOI： 10.1002/wps.20398

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  10 in total

1.  Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders.

Authors:  Eric Hollander; Sherie Novotny; Margaret Hanratty; Rona Yaffe; Concetta M DeCaria; Bonnie R Aronowitz; Serge Mosovich
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

Review 2.  Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics.

Authors:  Genoveva Uzunova; Stefano Pallanti; Eric Hollander
Journal:  World J Biol Psychiatry       Date:  2015-10-15       Impact factor: 4.132

Review 3.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

4.  A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

Authors:  Eric Hollander; Latha Soorya; William Chaplin; Evdokia Anagnostou; Bonnie P Taylor; Casara J Ferretti; Stacey Wasserman; Erika Swanson; Cara Settipani
Journal:  Am J Psychiatry       Date:  2012-03       Impact factor: 18.112

5.  Oxytocin increases retention of social cognition in autism.

Authors:  Eric Hollander; Jennifer Bartz; William Chaplin; Ann Phillips; Jennifer Sumner; Latha Soorya; Evdokia Anagnostou; Stacey Wasserman
Journal:  Biol Psychiatry       Date:  2006-08-14       Impact factor: 13.382

6.  A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism.

Authors:  Eric Hollander; Ann Phillips; William Chaplin; Karen Zagursky; Sherie Novotny; Stacey Wasserman; Rupa Iyengar
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

7.  Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders.

Authors:  Eric Hollander; William Chaplin; Latha Soorya; Stacey Wasserman; Sherry Novotny; Jade Rusoff; Nicole Feirsen; Lauren Pepa; Evdokia Anagnostou
Journal:  Neuropsychopharmacology       Date:  2009-12-09       Impact factor: 7.853

8.  STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.

Authors:  Craig A Erickson; Jeremy M Veenstra-Vanderweele; Raun D Melmed; James T McCracken; Lawrence D Ginsberg; Linmarie Sikich; Lawrence Scahill; Maryann Cherubini; Peter Zarevics; Karen Walton-Bowen; Randall L Carpenter; Mark F Bear; Paul P Wang; Bryan H King
Journal:  J Autism Dev Disord       Date:  2014-04

Review 9.  The challenges of clinical trials in fragile X syndrome.

Authors:  Sébastien Jacquemont; Elizabeth Berry-Kravis; Randi Hagerman; Florian von Raison; Fabrizio Gasparini; George Apostol; Mike Ufer; Vincent Des Portes; Baltazar Gomez-Mancilla
Journal:  Psychopharmacology (Berl)       Date:  2013-10-31       Impact factor: 4.530

10.  Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.

Authors:  Evdokia Anagnostou; Latha Soorya; William Chaplin; Jennifer Bartz; Danielle Halpern; Stacey Wasserman; A Ting Wang; Lauren Pepa; Nadia Tanel; Azadeh Kushki; Eric Hollander
Journal:  Mol Autism       Date:  2012-12-05       Impact factor: 7.509
  10 in total
  4 in total

1.  Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial.

Authors:  Elisa Santocchi; Letizia Guiducci; Margherita Prosperi; Sara Calderoni; Melania Gaggini; Fabio Apicella; Raffaella Tancredi; Lucia Billeci; Paola Mastromarino; Enzo Grossi; Amalia Gastaldelli; Maria Aurora Morales; Filippo Muratori
Journal:  Front Psychiatry       Date:  2020-09-25       Impact factor: 4.157

Review 2.  Genetics of glutamate and its receptors in autism spectrum disorder.

Authors:  Sabah Nisar; Ajaz A Bhat; Tariq Masoodi; Sheema Hashem; Sabah Akhtar; Tayyiba Akbar Ali; Sara Amjad; Sanjeev Chawla; Puneet Bagga; Michael P Frenneaux; Ravinder Reddy; Khalid Fakhro; Mohammad Haris
Journal:  Mol Psychiatry       Date:  2022-03-16       Impact factor: 13.437

3.  Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder.

Authors:  Sharon Hausman-Cohen; William LaValley; Heather Way; Emily Gutierrez; Jordan Reeder
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

Review 4.  Interventions on Microbiota: Where Do We Stand on a Gut-Brain Link in Autism? A Systematic Review.

Authors:  Margherita Prosperi; Elisa Santocchi; Letizia Guiducci; Jacopo Frinzi; Maria Aurora Morales; Raffaella Tancredi; Filippo Muratori; Sara Calderoni
Journal:  Nutrients       Date:  2022-01-20       Impact factor: 5.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.